Navigation Links


Alex's Lemonade Stand Foundation Announces Launch of Country's First Bioinformatics Lab Using 'Big Data' to Cure Childhood Cancer

6/27/2016
PHILADELPHIA , June 27, 2016  Alex's Lemonade Stand Foundation (ALSF), a leading national childhood cancer charity, announced that that it will open a state-of-the-art bioinformatics lab, using 'big data' to advance the pace of childhood cancer research. This announcement comes as Liz Scott , co-executive director of ALSF and Alex's mom, attends the National Ca... [Comments]

The Freedonia Group: World Enzyme Demand to Reach $7.2 Billion

6/27/2016
CLEVELAND , June 27, 2016  Global demand for enzymes is forecast to grow on average 4.6 percent through 2020 to $7.2 billion.  This market includes enzymes used in industrial applications (food and beverages, cleaning products, biofuel production, animal feed, and other markets) and specialty applications (research and biotechnology, diagnostics, and biocatalysts). Fo... [Comments]

Biorem Reports Sale of Securities by Major Shareholders

6/27/2016
GUELPH, ON , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") announces that it has been advised by its major shareholders, Clean Technology Fund I, LP and Clean Technology Fund II, LP, United States based venture capital funds which together hold approximately 59% of the common shares of Biorem (on a fully diluted, as converted basis), that they have... [Comments]

The Supreme Court Of The United States Denies Sequenom's Petition Requesting Review Of Decision On '540 Patent

6/27/2016
SAN DIEGO , June 27, 2016  Sequenom, Inc. (NASDAQ: SQNM ), a life sciences company committed to enabling healthier lives through the development of innovative products and services, announced today that the Supreme Court of the United States denied its petition to review decisions by lower Federal courts that the claims of Sequenom's U.S. Patent No. 6,258,540 ("'540... [Comments]

New Study Finds Activin A May be a Novel Mesothelioma Biomarker, According to Surviving Mesothelioma

6/27/2016
Raleigh, NC (PRWEB) June 27, 2016 Cancer experts from Austria, Hungary, Switzerland, and Australia have just published their findings on what they believe could be a new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just published a summary of the new re... [Comments]

Parallel 6™ Announces the Clinical Reach™ Virtual Patient Encounter Module, CONSULT

6/27/2016
San Diego, CA (PRWEB) June 27, 2016 Parallel 6 , the leading software as a service (SaaS) provider of mClinical solutions for clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication between t... [Comments]

4Sight Medical Solutions created to help the advancement of novel medical technologies

6/27/2016
Raleigh, NC (PRWEB) June 27, 2016 Newly created 4Sight Medical Solutions has a mission to bring innovative medical technologies, services and solutions to the healthcare market. The company's primary focus is on new product introductions, to include the development and implementation of... [Comments]

Amgen Executive Rolf Hoffmann Joins UNC Kenan-Flagler Business School

6/27/2016
Chapel Hill, N.C. (PRWEB) June 27, 2016 Rolf K. Hoffmann, former senior vice president of U.S. commercial operations for Amgen, will join the faculty of the University of North Carolina Kenan-Flagler Business School effective June 27. Hoffmann will serve as adjunct professor of strategy... [Comments]

Liquid Biotech USA, Inc. Announces Collaboration with the University of Pennsylvania and Funding of Sponsored Research Agreement

6/27/2016
PHILADELPHIA , June 27, 2016  Liquid Biotech USA , Inc. ("Liquid") today announced the funding of a Sponsored Research Agreement with The University of Pennsylvania ("PENN") to study circulating tumor cells (CTCs) from cancer patients.  The funding will be used to assess how changes in CTC levels correlate with clinical outcomes in cancer patients undergoing a vari... [Comments]

Ginkgo Bioworks Named as Technology Pioneer by World Economic Forum

6/27/2016
BOSTON , June 27, 2016   Ginkgo Bioworks , a leading organism design company bringing biology to industrial engineering, was today awarded as one of the World Economic Forum's Technology Pioneers, a selection of the world's most innovative companies. Ginkgo Bioworks is engineering biology to manufacture products at scale for the real world in the nutrition, health and... [Comments]

[next]
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
(Date:6/2/2016)... The Department of Transport Management (DOTM) ... million US Dollar project, for the , Supply ... Enrolment, and IT Infrastructure , to ... implementation of Identity Management Solutions. Numerous renowned international vendors participated ... was selected for the most compliant and innovative ...
(Date:6/2/2016)... 2016 Perimeter Surveillance & Detection ... Physical Infrastructure, Support & Other Service  The ... offers comprehensive analysis of the global Border Security ... revenues of $17.98 billion in 2016. Now: ... leader in software and hardware technologies for advanced video ...
Breaking Biology News(10 mins):
... PROTEAN II XL cell, wide format, is used for ... 20 cm gels and requires 1.2 L of running ... and the 2.0 mm IPG conversion kit, which contains ... includes 2 sets of IPG clamps, 2 sets of ...
... depletion cocktail is tailored to ... suspensions of rat spleen cells. ... StemSep (or compatible 0.5 Tesla) ... T cell content of the ...
... depletion cocktail is tailored to ... from suspensions of non-human primate ... separated using the StemSep (or ... selection system, achieving a 2.6 ...
... depletion cocktail is tailored to ... from suspensions of non-human primate ... separated using the StemSep compatible ... system. The CD4+ T cell ...
Biology Products:
(Date:6/23/2016)... -- Houston Methodist Willowbrook Hospital has signed a ... serve as their official health care provider. As ... provide sponsorship support, athletic training services, and most ... athletes and families. "We are excited ... to bring Houston Methodist quality services and programs ...
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
Breaking Biology Technology: